Market Tracker

10/31 7:05pm ET

Chembio Diagnostics Inc (NASDAQ:CEMI)

4.28
Data as of Oct 31
 -0.08 / -1.83%
Today’s Change
2.83
Today|||52-Week Range
5.20
+27.00%
Year-to-Date

Today’s Trading

Previous close4.36
Today’s open4.39
Day’s range4.24 - 4.39
Volume140,060
Average volume (3 months)94,803
Market cap$41.9M
Dividend yield--
Data as of 3:59pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)-45.45%
Earnings growth (this year)-266.67%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+15.38%
P/E ratio428.0
Price/Sales1.03
Price/Book2.01

Competitors

 Today’s
change
Today’s
% change
HTBXHeat Biologics Inc+0.15+2.34%
ENZNEnzon Pharmaceutical...-0.03-3.26%
NBYNovaBay Pharmaceutic...+0.01+1.26%
ANTHAnthera Pharmaceutic...-0.04-2.11%
Data as of 4:02pm ET, 10/31/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$29.5M
Annual profit (last year)$530.8K
Net profit margin1.80%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
John J. Sperzel
Chief Operating Officer
Sharon Klugewicz
Corporate headquarters
Medford, New York

Forecasts